ask="33.50"
ask_size="600"
average_daily_volume="1205200"
bid="26.15"
bid_size="200"
book_value="4.18"
change="-0.52"
change_from_200_day_moving_average="9.78"
change_from_50_day_moving_average="4.96"
change_from_52_week_high="-1.14"
change_From_52_week_low="16.46"
change_in_percent="-1.59%"
close="32.14"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.05"
ebitda="-278.87M"
eps_estimate_current_year="-4.92"
eps_estimate_next_quarter="-0.92"
eps_estimate_next_year="-3.40"
ex_dividend_date="N/A"
float_shares="45037000"
high="32.66"
high_52_weeks="33.28"
last_trade_date="2/22/2017"
last_trade_price="32.14"
last_trade_size="58105"
last_trade_time="4:00pm"
low="31.86"
low_52_weeks="15.68"
market_capitalization="1.82B"
moving_average_200_day="22.36"
moving_average_50_day="27.18"
name="Portola Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.75"
open="32.60"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+43.72%"
percent_change_from_50_day_moving_average="+18.27%"
percent_change_from_52_week_high="-3.43%"
percent_change_from_52_week_low="+104.97%"
previous_close="32.66"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.81"
price_per_sales="70.42"
revenue="26.23M"
shares_outstanding="56543000"
short_ratio="5.21"
stock_exchange="NMS"
symbol="PTLA"
volume="1051609"
weeks_range_52="15.68 - 33.28"
